Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
Péter L. Lakatos(McGill University)
Cited by 445
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Estrogen receptor alpha XbaI polymorphism, toxic adenoma, and thyroid hormone-stimulated bone loss
|UCL Discovery (University College London)|2004|0